To explore the potential transcriptomic discrepancy between type 1 and type 2 CALR-mutated MPN-model cells, we performed RNA sequencing (RNA-Seq) in CALRWT, CALRINS, and CALRDEL BaF3 cells. This evidence concerns the gene CALR and myeloproliferative neoplasm.